Scientists have found that a novel noncoding ribonucleic acid (RNA) offers the potential for “switching on” of tumor suppressors that have been shut off.
Scientists have found that a novel noncoding ribonucleic acid (RNA) offers the potential for “switching on” of tumor suppressors that have been shut off.